Windgap Medical, Inc.
WATERTOWN, MA · Founded 2011 · CIK 0001606077 · Medtech · Private
Autoinjector drug delivery devices for simplified, automated pharmaceutical administration
windgapmedical.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $41M
- 9 Form D · Nov 2023
- 35 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 18 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,494,500 | |
| Private capital raised· 1 of 2 same day | Form D · SEC | $3,713,875 | |
| Private capital raised· 2 of 2 same day | Form D · SEC | $250,000 | |
| Private capital raised | Form D · SEC | $2,889,618 | |
| Private capital raised | Form D · SEC | $1,020,566 | |
| Private capital raised | Form D · SEC | $12,151,193 | |
| Private capital raised | Form D · SEC | $360,500 | |
| Private capital raised | Form D · SEC | $17,001,923 | |
| Private capital raised | Form D · SEC | $2,300,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1022 | VAPOGENIX, INC. | — | $12M |
| 1023 | Boston Incubation Center LLC | — | — |
| 1024 | Fio Corp | — | $11M |
| 1025 | Windgap Medical, Inc. | — | $41M |
| 1026 | Greenwings Biomedical, Inc. | — | — |
| 1027 | Spheryx, Inc. | — | $1.7M |
| 1028 | Angiotech Pharmaceuticals | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Brent BuchineDirector · Executive Officer
- John CadiganExecutive Officer
- John ConleyDirector
- Jason DurkinExecutive Officer
- J. EngleDirector
- Richard GabrielDirector
- Michael HuangDirector
- Tim KrochukDirector · Executive Officer
- Timothy KrochukDirector
- Aaron MannDirector · Executive Officer
- William McKeeDirector
- Max MeehanExecutive Officer
- Richard RussellDirector
- Michael SamarExecutive Officer
- Christopher StepanianDirector · Executive Officer
- Anthony WatsonExecutive Officer
- John WilsonDirector
Patents
- Sequential Delivery Systems And Methodsapplication
- Automated And Semi-automated Mixing And Automated Delivery Autoinjectorapplication
- Autoinjector Training Devicegranted
- Portable Drug Mixing And Delivery Device And Associated Methodsapplication
- Drug Mixing And Delivery System And Methodgranted
- Portable Drug Mixing And Delivery Device And Associated Methodsgranted
- System And Method For Providing And Assembling An Auto-injectorgranted
- Dynamic Mixing And Delivery System For Mixing A Therapeutic Agent In An Injector Or Autoinjectorapplication
- Dynamic Mixing And Delivery System For Mixing A Therapeutic Agent In An Injector Or Autoinjectorgranted
- Reciprocating Mixing And Injector Systemapplication
- Method And Compositions For Dissolving Or Solubilizing Therapeutic Agentsgranted
- Mixing And Injection Device With Sterility Featuresgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.